We announced our financial results for the first three months of 2023.

Q1 company announcement

Q1 Investor presentation

Q1 financial workbook (xlsx)

Q1 earnings conference call webcast

 

London conference call - 9 May 2023
London conference call webcast

The Q2 2023 financial results release will  be published in a company announcement at 07.30 CET.

The Q3 2023 financial results release will  be published in a company announcement at 07.30 CET.

Full-year 2023 financial results will be published in 2024.

Learn more about this year's Annual General Meeting here

R&D investor call in relation to ADA 2023
Novo Nordisk A/S will host a R&D investor call in relation to the annual ADA conference, in June 2023. This year the conference is hosted in San Diego, CA.

Our R&D investor call will take place on:

25 June at 19:30 – 20:45 PDT
25 June at 22:30 – 23:45 EDT
26 June at 03:30 – 04:45 BST
26 June at 04:30 – 05:45 CEST

Webcast will be available via following link: https://edge.media-server.com/mmc/p/ir46mqps

All upcoming investor relations events

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
reCAPTCHA verification required

Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Visit Capital Markets Day Stock information Press releases and company announcements R&D pipeline Upcoming events

Annual Report

Cover page of the Novo Nordisk Annual Report 2022

Annual Report 2022

Download Annual Report